If restarting sooner is important for your health, the safest approach is to make a plan with your healthcare team as appropriate
Despite challenges like high treatment costs, the market is anticipated to expand further, fueled by increasing clinical evidence, new regulatory approvals for additional indications, and the development of more affordable alternatives
This underscores the need for both RWE and RCTs in parallel and reinforces the need to need to run clinical trials that reflect real-world populations, a topic explored in more detail in our blog Obesity trials on trial Some health improvement seen with GLP-1 therapy may be a direct effect of weight loss, rather than unique drug effect as seen by improvements in liver and kidney health 4
Biochemical and Biophysical Research Communications 310, 824-829CrossRefGoogle ScholarPubMed 76Sasaki, H., Sato, H., Kuriyama-Matsumura, K